Traws Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 260.6%.

Top 25 shareholders own 26.94% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20%	OrbiMed Advisors LLC	605,531	€2.8m	1,350%	0.04%
2.18%	Viriom Inc.	65,804	€303.1k	0%	no data
1.66%	Nikolay Savchuk	50,083	€230.7k	31.5%	no data
0.93%	The Vanguard Group, Inc.	28,276	€130.2k	-0.24%	no data
0.48%	Iain Dukes	14,662	€67.5k	450%	no data
0.33%	BlackRock, Inc.	9,955	€45.8k	0%	no data
0.3%	Geode Capital Management, LLC	8,963	€41.3k	16.2%	no data
0.29%	Renaissance Technologies LLC	8,723	€40.2k	-18.7%	no data
0.16%	Citadel Advisors LLC	4,840	€22.3k	229%	no data
0.13%	UBS Asset Management AG	3,943	€18.2k	39,300%	no data
0.099%	Steven Fruchtman	2,992	€13.8k	-28.6%	no data
0.079%	State Street Global Advisors, Inc.	2,403	€11.1k	13.8%	no data
0.052%	Mark Guerin	1,571	€7.2k	0.06%	no data
0.041%	Northern Trust Global Investments	1,226	€5.6k	-0.41%	no data
0.036%	Virtu Financial LLC, Asset Management Arm	1,094	€5.0k	0%	no data
0.033%	Jane Street Group, LLC, Asset Management Arm	1,002	€4.6k	0%	no data
0.028%	James Marino	853	€3.9k	0%	no data
0.024%	Morgan Stanley, Investment Banking and Brokerage Investments	730	€3.4k	-3.18%	no data
0.022%	Viren Mehta	669	€3.1k	0%	no data
0.017%	Beacon Pointe Advisors, LLC	508	€2.3k	-7.8%	no data
0.014%	Mark Gelder	419	€1.9k	0%	no data
0.0088%	Edmond de Rothschild Asset Management (France)	266	€1.2k	0%	no data
0.0068%	Vermillion & White Wealth Management Group LLC	205	€944.7	0%	no data
0.0046%	Tower Research Capital Europe Limited	140	€645.1	0.72%	no data
0.0045%	Mary Shoemaker	136	€627.0	0.74%	no data